153 related articles for article (PubMed ID: 2143893)
1. Treatment of hypercalcaemia of malignancy.
Heath DA
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia of malignancy: diagnosis and therapy.
Fetchick DA; Mundy GR
Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcaemia due to malignancy. Role of the kidney and treatment.
Sleeboom HP; Bijvoet OL
Contrib Nephrol; 1982; 33():178-96. PubMed ID: 6214375
[No Abstract] [Full Text] [Related]
4. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
Ralston SH; Gardner MD; Dryburgh FJ; Jenkins AS; Cowan RA; Boyle IT
Lancet; 1985 Oct; 2(8461):907-10. PubMed ID: 2865417
[TBL] [Abstract][Full Text] [Related]
5. Drug therapy of hypercalcemia due to malignancy.
Raue F; Pecherstorfer M
Recent Results Cancer Res; 1994; 137():138-60. PubMed ID: 7878293
[No Abstract] [Full Text] [Related]
6. Hypercalcaemia and myeloma.
Delamore IW
Br J Haematol; 1982 Aug; 51(4):507-9. PubMed ID: 6213257
[No Abstract] [Full Text] [Related]
7. Comparative tolerability of drug therapies for hypercalcaemia of malignancy.
Zojer N; Keck AV; Pecherstorfer M
Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hypercalcemia associated with malignancy.
Mazzaferri EL; O'Dorisio TM; LoBuglio AF
Semin Oncol; 1978 Jun; 5(2):141-53. PubMed ID: 150032
[No Abstract] [Full Text] [Related]
9. Diagnosis and management of hypercalcemia.
Kukreja SC
Compr Ther; 1980 Aug; 6(8):33-8. PubMed ID: 6447571
[No Abstract] [Full Text] [Related]
10. Medical management of the hypercalcemia of malignancy.
Deftos LJ; Neer R
Annu Rev Med; 1974; 25(0):323-31. PubMed ID: 4277568
[No Abstract] [Full Text] [Related]
11. Intravenous phosphate solution for treatment of hypercalcemia.
Med Lett Drugs Ther; 1974 Sep; 16(19):78-9. PubMed ID: 4279326
[No Abstract] [Full Text] [Related]
12. Hypercalcemia.
Bilezikian JP
Curr Ther Endocrinol Metab; 1994; 5():511-4. PubMed ID: 7704784
[No Abstract] [Full Text] [Related]
13. Hypercalcemia: diagnosis and therapy.
Canalis EM; Mundy GR; Raisz LG
Conn Med; 1977 Jan; 41(1):16-21. PubMed ID: 137799
[No Abstract] [Full Text] [Related]
14. Comparative study of available medical therapy for hypercalcemia of malignancy.
Mundy GR; Wilkinson R; Heath DA
Am J Med; 1983 Mar; 74(3):421-32. PubMed ID: 6219578
[TBL] [Abstract][Full Text] [Related]
15. Therapy of malignancy-associated hypercalcemia: 1983.
Stewart AF
Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and management of cancer associated hypercalcaemia.
Ralston SH
Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy.
Khan AA; Gurnani PK; Peksa GD; Whittier WL; DeMott JM
Ann Pharmacother; 2021 Mar; 55(3):277-285. PubMed ID: 32885992
[TBL] [Abstract][Full Text] [Related]
18. Medical management of hypercalcaemia.
Ralston SH
Br J Clin Pharmacol; 1992 Jul; 34(1):11-20. PubMed ID: 1633063
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemic crisis.
O'Dorisio TM
Heart Lung; 1978; 7(3):425-34. PubMed ID: 148440
[No Abstract] [Full Text] [Related]
20. Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation.
Rawlinson PS; Green RH; Coggins AM; Boyle IT; Gibson BE
Arch Dis Child; 1991 May; 66(5):638-9. PubMed ID: 2039258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]